Rehabilitation of People With Post-tuberculosis Lung Disease
Conditions: Pulmonary Tuberculosis Interventions: Other: Standard care plus pulmonary rehabilitation; Other: Standard Care Sponsors: Centro Universit ário Augusto Motta; Rio de Janeiro State University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials
A Multicenter Clinical Trial of Ingaron in Pulmonary Tuberculosis
Conditions: Respiratory Tuberculosis Interventions: Drug: Interferon-Gamma Sponsors: SPP Pharmaclon Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 7, 2023 Category: Research Source Type: clinical trials
Clinical Testing of the Drug Ingaron as Part of Complex Therapy in Adult Patients With Tuberculosis
Conditions: Respiratory Tuberculosis Interventions: Drug: Interferon-Gamma Sponsors: SPP Pharmaclon Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 6, 2023 Category: Research Source Type: clinical trials
Platform Assessing Regimens and Durations In a Global Multisite Consortium for TB
Conditions: Pulmonary Tuberculosis Interventions: Drug: GSK3036656; Drug: BTZ-043; Drug: Bedaquiline (B); Drug: Delamanid (D); Drug: Pretomanid (Pa); Drug: Moxifloxacin (M); Drug: Linezolid (L); Drug: Pyrazinamide (Z); Drug: Rifampicin (R); Drug: Isoniazid (H); Drug: Ethambutol (E) Sponsors: University College, London; Radboud University Medical Center; London School of Hygiene and Tropical Medicine; University of Oxford; Research Center Borstel; Lygature; TASK Applied Science; Vita-Salute San Raffaele University; Helmholtz Zentrum Munchen; KNCV Tuberculosis Foundation; Critical Path Institute; European Lung Foundation; In...
Source: ClinicalTrials.gov - November 2, 2023 Category: Research Source Type: clinical trials
Diagnostic Innovations for Pediatric Tuberculosis in Bolivia
Conditions: Tuberculosis Interventions: Diagnostic Test: Quantiferon Gold; Diagnostic Test: HIV serology; Diagnostic Test: Respiratory secretion culture (sputum or gastric aspirate_; Diagnostic Test: Chest radiograph; Diagnostic Test: Lung ultrasound; Diagnostic Test: cell free DNA test Sponsors: Tulane University; Asociacion Benefica Prisma; Universidad Peruana Cayetano Heredia; Johns Hopkins Bloomberg School of Public Health Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2023 Category: Research Source Type: clinical trials
Epidemiological Study of Hospitalized Children for Pulmonary Tuberculosis at Strasbourg University Hospitals
Conditions: Pulmonary Tuberculosis Sponsors: University Hospital, Strasbourg, France Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 31, 2023 Category: Research Source Type: clinical trials
The INSTITUT Study
Conditions: Tuberculosis, Pulmonary; Undernutrition Interventions: Other: Nutritional support Sponsors: Boston Medical Center; The International Union Against Tuberculosis and Lung Disease Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 16, 2023 Category: Research Source Type: clinical trials
Innovating Shorter, All- Oral, Precised, Individualized Treatment Regimen for Rifampicin Resistant Tuberculosis ：Contizolid and Dlamanid Cohort
Conditions: Pulmonary Tuberculosis; Rifampicin-resistant Tuberculosis Interventions: Drug: Bedaquiline; Drug: Delamanid; Drug: Contezolid; Drug: Levofloxacin; Drug: Moxifloxacin; Drug: Clofazimine; Drug: Linezolid; Drug: Cycloserine; Drug: Prothionamide; Drug: Pyrazinamide; Drug: Para-Aminosalicylic Acid; Drug: Ethambutol Sponsors: Beijing Chest Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 13, 2023 Category: Research Source Type: clinical trials
The Clinical Characteristics, Treatment and Prognosis of Tuberculosis-associated COPD
Conditions: COPD Interventions: Other: previous pulmonary tuberculosis Sponsors: Peking University Third Hospital; Peking University Shougang Hospital; The First Affiliated Hospital of Guangzhou Medical University; First Hospital of China Medical University; West China Hospital; Shanxi Bethune Hospital; Tibet Autonomous Region People ' s Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 9, 2023 Category: Research Source Type: clinical trials
Bacillus Calmette-Gu érin vaccination as defense against SARS-CoV-2 (BADAS): a randomized controlled trial to protect healthcare workers in the USA by enhanced trained immune responses
DiscussionIt is expected this trial will allow evaluation of the effects of BCG vaccination at a population level in high-risk healthcare individuals through a mitigated clinical course of SARS-CoV-2 infection and inform policy making during the ongoing epidemic.Trial registrationClinicalTrials.gov NCT04348370. Registered on April 16, 2020. (Source: Trials)
Source: Trials - October 4, 2023 Category: Research Source Type: clinical trials
Study to Assess Efficacy and Safety of M72/AS01E-4 Mycobacterium Tuberculosis (Mtb) Vaccine in Adolescents and Adults
Conditions: Tuberculosis Interventions: Biological: M72/AS01E-4 Mycobacterium tuberculosis investigational vaccine; Biological: Placebo Sponsors: Bill& Melinda Gates Medical Research Institute; Wellcome Trust; Bill and Melinda Gates Foundation Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 2, 2023 Category: Research Source Type: clinical trials
Sensitivity and Specificity of Xpert MTB/RIF Ultra
Condition: Tuberculosis Intervention: Sponsor: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2023 Category: Research Source Type: clinical trials
Phase 2 Trial Assessing TBAJ876 or Bedaquiline, With Pretomanid and Linezolid in Adults With Drug-sensitive Pulmonary Tuberculosis
Conditions: Pulmonary TB; Pulmonary Tuberculosis; Drug Sensitive Tuberculosis Interventions: Drug: TBAJ-876; Drug: Pretomanid; Drug: Linezolid; Drug: Bedaquiline; Drug: HRZE; Drug: HR Sponsor: Global Alliance for TB Drug Development Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2023 Category: Research Source Type: clinical trials
Sensitivity and Specificity of Xpert MTB/RIF Ultra
Conditions: Tuberculosis Sponsors: Assiut University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2023 Category: Research Source Type: clinical trials
Phase 2 Trial Assessing TBAJ876 or Bedaquiline, With Pretomanid and Linezolid in Adults With Drug-sensitive Pulmonary Tuberculosis
Conditions: Pulmonary TB; Pulmonary Tuberculosis; Drug Sensitive Tuberculosis Interventions: Drug: TBAJ-876; Drug: Pretomanid; Drug: Linezolid; Drug: Bedaquiline; Drug: HRZE; Drug: HR Sponsors: Global Alliance for TB Drug Development Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2023 Category: Research Source Type: clinical trials
